Published in Lancet on August 03, 1974
Structure and organization of the hepatitis C virus genome isolated from human carriers. J Virol (1991) 8.33
Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci U S A (1990) 6.96
Genomic structure of the human prototype strain H of hepatitis C virus: comparison with American and Japanese isolates. Proc Natl Acad Sci U S A (1991) 3.34
The GB viruses: a review and proposed classification of GBV-A, GBV-C (HGV), and GBV-D in genus Pegivirus within the family Flaviviridae. J Gen Virol (2010) 2.26
Detection of antibody against antigen expressed by molecularly cloned hepatitis C virus cDNA: application to diagnosis and blood screening for posttransfusion hepatitis. Proc Natl Acad Sci U S A (1990) 2.12
Hepatitis E virus: identification of type-common epitopes. J Virol (1991) 1.95
Improved serodiagnosis of hepatitis C virus infection with synthetic peptide antigen from capsid protein. Proc Natl Acad Sci U S A (1991) 1.81
The economic impact of viral hepatitis in the United States. Public Health Rep (1976) 1.67
Regulated processing of hepatitis C virus core protein is linked to subcellular localization. J Virol (1997) 1.63
The history of the "natural history" of hepatitis C (1968-2009). Liver Int (2009) 1.63
Institutional outbreaks of rotavirus diarrhoea: potential role of fomites and environmental surfaces as vehicles for virus transmission. J Hyg (Lond) (1986) 1.57
Hepatitis C: progress and problems. Clin Microbiol Rev (1994) 1.37
Inactivation of hepatitis B virus and non-A, non-B hepatitis by chloroform. Infect Immun (1983) 1.35
A prospective study of acute viral hepatitis with particular reference to hepatitis A. Bull World Health Organ (1976) 1.26
Identification of an immunodominant epitope within the capsid protein of hepatitis C virus. Proc Natl Acad Sci U S A (1991) 1.18
Acute type A, B, and non-A, non-B hepatitis in a hospital population in London: clinical and epidemiological features. Gut (1983) 1.13
Detection of hepatitis B surface antigen among Scottish blood donors: evaluation of sensitive tanned-cell haemagglutination-inhibition test. Br Med J (1975) 1.03
Morphology of hepatitis C and hepatitis B virus particles as detected by immunogold electron microscopy. Med Mol Morphol (2006) 0.86
Detection and transmission in chimpanzees of hepatitis B virus-related agents formerly designated "non-A, non-B" hepatitis. Proc Natl Acad Sci U S A (1982) 0.85
Hepatitis C: Treatment triumphs. Nature (2014) 0.82
Non-A, non-B hepatitis. Yale J Biol Med (1976) 0.82
Mortality and morbidity among military personnel and civilians during the 1930s and World War II from transmission of hepatitis during yellow fever vaccination: systematic review. Am J Public Health (2013) 0.81
Historical review of the causes of cancer. World J Clin Oncol (2016) 0.79
Hepatitis non-A, non-B. Can Med Assoc J (1980) 0.79
HCV animal models: a journey of more than 30 years. Viruses (2009) 0.78
To study the prevalence of impaired glucose tolerance in patients with hepatitis C virus related chronic liver disease. J Clin Diagn Res (2015) 0.77
Human Immunoglobulins for intravenous use and hepatitis C viral transmission. Clin Diagn Lab Immunol (1994) 0.77
Viral hepatitis, type B. Yale J Biol Med (1976) 0.76
Editorial: The several viruses of post-transfusion hepatitis. Br Med J (1975) 0.75
Which techniques should be used to screen blood donations for hepatitis B surface antigen? Br Med J (1975) 0.75
Infectious diseases: fortieth and final annual review of significant publications. Postgrad Med J (1975) 0.75
Serology and epidemiology. West J Med (1975) 0.75
Non-A non-B hepatitis. Br Med J (1978) 0.75
Promising developments in viral hepatitis. West J Med (1975) 0.75
Hepatitis in the 1980s. Am J Public Health (1979) 0.75
Non-A, non-B hepatitis: dead ends or new horizons? Br Med J (Clin Res Ed) (1987) 0.75
An antigen detected in the blood during the incubation period of serum hepatitis. Proc Natl Acad Sci U S A (1968) 7.33
Seroprevalence of human immunodeficiency virus among childbearing women. Estimation by testing samples of blood from newborns. N Engl J Med (1988) 6.00
Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp Neurol (2000) 4.56
On the role of sexual behavior in the spread of hepatitis B infection. Ann Intern Med (1975) 4.11
The pathogenesis of Shigella diarrhea. I. Enterotoxin production by Shigella dysenteriae I. J Clin Invest (1972) 4.05
Serum hepatitis antigen (SH): rapid detection by high voltage immunoelectroosmophoresis. Science (1970) 4.00
Tandem mass spectrometric analysis for amino, organic, and fatty acid disorders in newborn dried blood spots: a two-year summary from the New England Newborn Screening Program. Clin Chem (2001) 3.37
Genomic structure of the human prototype strain H of hepatitis C virus: comparison with American and Japanese isolates. Proc Natl Acad Sci U S A (1991) 3.34
Prevalence of HIV infection in childbearing women in the United States. Surveillance using newborn blood samples. JAMA (1991) 2.94
The pathogenesis of shigella diarrhea. II. Enterotoxin-induced acute enteritis in the rabbit ileum. J Infect Dis (1972) 2.87
The role of circulating hepatitis B antigen/antibody immune complexes in the pathogenesis of vascular and hepatic manifestations in polyarteritis nodosa. J Clin Pathol (1974) 2.85
Hepatitis B virus vaccine: identification of HBsAg/a and HBsAg/d but not HBsAg/y subtype antigenic determinants on a synthetic immunogenic peptide. Proc Natl Acad Sci U S A (1982) 2.52
Failure of a human immunodeficiency virus (HIV) immune globulin to protect chimpanzees against experimental challenge with HIV. Proc Natl Acad Sci U S A (1988) 2.47
Immunity in hepatitis C infection. J Infect Dis (1992) 2.28
Sensitivity of serological assays to identify blood donors with hepatitis C viraemia. Lancet (1992) 2.25
HIV seroprevalence surveys of childbearing women--objectives, methods, and uses of the data. Public Health Rep (1990) 2.20
Immunologic distinction between infectious and serum hepatitis. N Engl J Med (1970) 2.16
A serologic study of cytomegalovirus infections associated with blood transfusions. N Engl J Med (1971) 2.02
Hepatitis B infection. A point-prevalence study in 15 US hemodialysis centers. JAMA (1974) 1.92
Specificity of the direct solid-phase radioimmunoassay for detection of hepatitis-B antigen. Lancet (1973) 1.89
Detection of antibody to Varicella-Zoster virus by immune adherence hemagglutination. Proc Soc Exp Biol Med (1976) 1.88
Role of serum hepatitis virus in chronic liver disease. Gastroenterology (1971) 1.84
Isolation of a simian immunodeficiency virus related to human immunodeficiency virus type 2 from a west African pet sooty mangabey. J Virol (1991) 1.82
Relation of Mycoplasma pneumoniae seroreactivity, immunosuppression, and chronic disease to Legionnaires' disease. A twelve-month prospective study of sporadic cases in Massachusetts. Ann Intern Med (1979) 1.82
Early detection of human immunodeficiency virus on dried blood spot specimens: sensitivity across serial specimens. Women and Infants Transmission Study Group. J Pediatr (1996) 1.79
Relation of Australia and SH antigens. Lancet (1968) 1.75
Viral hepatitis in a group of Boston hospitals. 3. Importance of exposure to shellfish in a nonepidemic period. N Engl J Med (1967) 1.75
Viral syndromes and renal homograft rejection. Ann Surg (1972) 1.74
Hepatitis B antigen (HBSAg) and/or antibodies (anti-HBS and anti-HBC) in fulminant hepatitis: pathogenic and prognostic significance. Gut (1976) 1.74
Pathogenesis of bacterial diarrheas. I. N Engl J Med (1971) 1.71
The association of viral and mycoplasma infections with recurrence of wheezing in the asthmatic child. Ann Allergy (1970) 1.70
Antibodies to a synthetic peptide from the preS 120-145 region of the hepatitis B virus envelope are virus neutralizing. Vaccine (1986) 1.68
Hepatitis B "immune" globulin: effectiveness in prevention of dialysis-associated hepatitis. N Engl J Med (1975) 1.66
Active transport of sodium by human colon in vitro. Gastroenterology (1970) 1.66
Antibody-dependent enhancement of human immunodeficiency virus type 1 (HIV-1) infection in vitro by serum from HIV-1-infected and passively immunized chimpanzees. Proc Natl Acad Sci U S A (1989) 1.64
Passive immunotherapy in the treatment of advanced human immunodeficiency virus infection. J Infect Dis (1993) 1.63
Regulated processing of hepatitis C virus core protein is linked to subcellular localization. J Virol (1997) 1.63
Production and characterization of exotoxin(s) of Shigella dysenteriae type 1. J Infect Dis (1975) 1.56
Familial clustering of hepatitis B infection. N Engl J Med (1973) 1.56
Low level rubella immunity detected by ELISA and specific lymphocyte transformation. Arch Virol (1980) 1.55
Detection and characterization of blood group antigens on untransformed human amnion cells. Transfusion (1968) 1.53
Hepatitis B vaccine in health care personnel: safety, immunogenicity, and indicators of efficacy. Ann Intern Med (1984) 1.52
S.H. antigen and chronic liver disease. Lancet (1970) 1.51
Variable behaviour of blood group H on HeLa cell populations synchronized with thymidine. Nature (1968) 1.49
Intrafamilial spread of asymptomatic hepatitis B. Am J Med Sci (1977) 1.48
Prevention of HIV-1 IIIB infection in chimpanzees by CD4 immunoadhesin. Nature (1991) 1.47
Hepatitis B antigen and antibody in blood donors: an epidemiologic study. J Infect Dis (1973) 1.46
Coxsackievirus and adenovirus infection. Association with acute febrile and juvenile rheumatoid arthritis. JAMA (1976) 1.45
The use of tri(n-butyl)phosphate detergent mixtures to inactivate hepatitis viruses and human immunodeficiency virus in plasma and plasma's subsequent fractionation. Transfusion (1990) 1.45
Gamma-glutamyltransferase as a potential surrogate marker for detection of the non-A, non-B carrier state. Vox Sang (1988) 1.44
The epidemiology of hepatitis B infections in Africa: results of a pilot survey in the Republic of Senegal. Am J Epidemiol (1973) 1.43
Prevalence of serum-hepatitis-related antigen (SH) in different geographic regions. Am J Trop Med Hyg (1970) 1.42
Identifying human immunodeficiency virus infection at birth: application of polymerase chain reaction to Guthrie cards. J Pediatr (1993) 1.41
The epidemiology of serum hepatitis (SH) infections: a controlled study in two closed institutions. Am J Epidemiol (1971) 1.40
Sounding board. Use of hepatitis B immuneglobulin:reassessment needed. N Engl J Med (1978) 1.40
Virulent HIV strains, chimpanzees, and trial vaccines. Science (1999) 1.40
Virus-like particles in human plasma and serum: role of platelet lysosomes. J Natl Cancer Inst (1966) 1.39
Prevalence, clinical significance, and strain specificity of neutralizing antibody to the human immunodeficiency virus. J Infect Dis (1987) 1.38
Production of albumin and other serum proteins by clonal cultures of normal human liver. Proc Natl Acad Sci U S A (1971) 1.38
The development of virus-free labile blood derivatives--a review. Eur J Epidemiol (1987) 1.33
Molecular cloning and characterization of onchocystatin, a cysteine proteinase inhibitor of Onchocerca volvulus. J Biol Chem (1992) 1.33
Role of immune complexes involving SH antigen in pathogenesis of chronic active hepatitis and polyarteritis nodosa. Lancet (1971) 1.30
Clinical signs of the pseudoexfoliation syndrome. Ophthalmology (1986) 1.29
Serum hepatitis specific antigen (SH) in commercial and volunteer sources of blood. Transfusion (1971) 1.29
Development and distribution of hemagglutinating antibody against the hepatitis B antigen in institutionalized populations. J Infect Dis (1972) 1.28
Cytomegalovirus immune globulin prophylaxis in liver transplantation. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1993) 1.27
Hepatitis B antigen in wild-caught mosquitoes in Africa. Lancet (1972) 1.27
Identification of additional antigenic sites on Dane particles and the tubular forms of hepatitis B surface antigen. J Gen Virol (1976) 1.25
Preclinical diagnosis of pseudoexfoliation syndrome. Arch Ophthalmol (1987) 1.25
Sodium transport by human ileum in vitro and its response to cholera enterotoxin. Gastroenterology (1967) 1.25
A case/control study of the association between primary liver cancer and hepatitis B infection in Senegal. Int J Cancer (1975) 1.24
Accidental hepatitis-B-surface-antigen-positive inoculations. Use of e antigen to estimate infectivity. Ann Intern Med (1982) 1.24
Use of conserved sequences from hepatitis C virus for the detection of viral RNA in infected sera by polymerase chain reaction. Hepatology (1991) 1.23
Solvent/detergent-treated plasma: a virus-inactivated substitute for fresh frozen plasma. Blood (1992) 1.22
Three different patterns of hepatitis C virus infection in chimpanzees. Hepatology (1992) 1.21
Hypericin as an inactivator of infectious viruses in blood components. Transfusion (1995) 1.19
Identification of an immunodominant epitope within the capsid protein of hepatitis C virus. Proc Natl Acad Sci U S A (1991) 1.18
Role of arthropods in transmission of hepatitis-B virus in the tropics. Lancet (1973) 1.17
Passive immunization with a human immunodeficiency virus type 1-neutralizing monoclonal antibody in Hu-PBL-SCID mice: isolation of a neutralization escape variant. J Infect Dis (1998) 1.15
Eastern equine encephalitis in Massachusetts, 1957-1976. A prospective study centered upon analyses of mosquitoes. Am J Epidemiol (1978) 1.14
Pharmacokinetics, safety, and antiviral effects of hypericin, a derivative of St. John's wort plant, in patients with chronic hepatitis C virus infection. Antimicrob Agents Chemother (2001) 1.14
Detection of virus-associated antigen in serum and liver of patients with non-A non-B hepatitis. Lancet (1979) 1.14
The serum hepatitis related antigen (SH) in illicit drug users. Am J Epidemiol (1970) 1.13
Pathogenesis of bacterial diarrheas (second of two parts). N Engl J Med (1971) 1.13
Preparation of human hyperimmune globulin to Haemophilus influenzae b, Streptococcus pneumoniae, and Neisseria meningitidis. Infect Immun (1984) 1.12
Chronic liver disease in asymptomatic narcotic addicts. Ann Intern Med (1972) 1.10